✕

Breaking

New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·

Tag

Obesity

Semaglutide Reduces Major Cardiovascular Events by 26% in Obese Patients Without Diabetes, Landmark Study Finds

Semaglutide Reduces Major Cardiovascular Events by 26% in Obese Patients Without Diabetes, Landmark Study Finds

Dr. Sarah ChenMar 11, 2026 · 2 min read

Childhood Obesity Rates Fall for First Time in 30 Years Following School Nutrition Policy Changes, CDC Reports

Childhood Obesity Rates Fall for First Time in 30 Years Following School Nutrition Policy Changes, CDC Reports

Dr. Sarah ChenMar 8, 2026 · 2 min read

Tirzepatide Achieves 22% Body Weight Loss in Largest Obesity Drug Trial Ever Conducted

Tirzepatide Achieves 22% Body Weight Loss in Largest Obesity Drug Trial Ever Conducted

Dr. Priya NairMar 5, 2026 · 2 min read

First Oral GLP-1 Drug Approved: Rybelsus Upgraded Formulation Shows Weight Loss Equivalent to Weekly Injections

First Oral GLP-1 Drug Approved: Rybelsus Upgraded Formulation Shows Weight Loss Equivalent to Weekly Injections

Dr. Sarah ChenFeb 26, 2026 · 2 min read